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Aims: This study investigated the occurrence and genetic diversity of Enterobacteriaceae with 23 
Extended-Spectrum Beta-Lactamase (ESBL), AmpC and carbapenemase mediated resistance in 24 
British beef cattle, and related risk factors.  25 
Methods and Results: Faecal samples (n=776) were obtained from farms in England & Wales 26 
(n=20) and Scotland (n=20) in 2015. Isolates from selective agars were identified by MALDI ToF 27 
mass spectrometry. Selected isolates were characterised by multiplex PCR (blaCTX-M, blaOXA, blaSHV 28 
and blaTEM genes), whole genome sequencing (WGS), MICs and PFGE. None of the faecal samples 29 
yielded carbapenem resistant E. coli. Ten (25%) of the farms tested positive for ESBL-producing 30 
CTX-M Enterobacteriaceae, fifteen (37.5%) of the farms were positive for AmpC phenotype E. coli 31 
and none were positive for carbapenem resistant E. coli. WGS showed a total of 30 different 32 
resistance genes associated with E. coli, Citrobacter and Serratia from ESBL agars, and co-location 33 
of resistance genes with blaCTX-M1. Buying bulls and bringing in fattening cattle from another farm 34 
were identified as significant risk factors for positive samples harbouring CTX-M 35 
Enterobacteriaceae or AmpC phenotype E. coli respectively.   36 
Conclusions: Beef cattle on a proportion of farms in GB carry ESBL-producing 37 
Enterobacteriaceae. Factors, such as operating as a closed herd, may have an important role in 38 
reducing introduction and transmission of resistant Enterobacteriaceae. The results indicate 39 
management factors may play an important role in impacting ESBL prevalence. In particular, 40 
further study would be valuable to understand the impact of maintaining a closed herd on reducing 41 
the introduction of resistant Enterobacteriaceae. 42 
 43 
Significance and Impact of the study: This is the first study showing the presence of ESBL-44 
producing Enterobacteriaceae in British beef cattle.  45 
 46 
Keywords: Antibiotics, Enterobacteria, Epidemiology, Resistance, Veterinary 47 
 48 
49 
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Introduction 50 
Antimicrobial resistance (AMR) is of major concern for both animal and human health. In recent 51 
years Enterobacteriaceae with extended-spectrum β-lactamases (ESBLs) have been associated with 52 
increased resistance to critically important cephalosporin antibiotics (Canton and Coque, 2006, 53 
Schmid et al., 2013), and have been increasingly isolated from humans (Lau et al., 2008), including 54 
healthy people (Kirchner et al., 2013, Card et al., 2014, Card et al., 2015, Kirchner et al., 2017), 55 
companion animals (Carattoli et al., 2005), food animals (Horton et al., 2011, Randall et al., 2011, 56 
Randall et al., 2014a, Kirchner et al., 2017), including some that also harbour mcr plasmid mediated 57 
colistin resistance (Figueiredo et al., 2016, Duggett et al., 2018), and some foods (Warren et al., 58 
2008, Egea et al., 2012, Kola et al., 2012, Petternel et al., 2014, van Hoek et al., 2015, Tekiner and 59 
Özpınar, 2016). The resistance is mainly conferred by ESBL enzymes, which are normally plasmid 60 
encoded, and of which the CTX-M group has become a dominant type, particularly in Escherichia 61 
coli (Snow et al., 2012, Schmid et al., 2013). Whilst in a human clinical setting, increased mortality 62 
for bloodstream infections due to ESBL-producing E. coli versus non-ESBL E. coli has previously 63 
been reported (Gastmeier et al., 2012), previous studies suggest that clonal spread of isolates from 64 
food and farm animals to humans is unlikely, although dissemination of genes encoding plasmid 65 
mediated AmpC (pAmpC)/ESBL may occur (de Been et al., 2014, Bonten and Mevius, 2015, 66 
Borjesson et al., 2016). 67 
Prevalence of ESBL-producing E. coli in cattle has been demonstrated to vary greatly between 68 
countries; ranging from 35.4% to 86.7% of positive farms and from 1% to 32.8% of positive 69 
animals (Snow et al., 2012, Schmid et al., 2013, Dorado-Garcia et al., 2016, Gonggrijp et al., 2016, 70 
Hille et al., 2017). In the United Kingdom, the first case of CTX-M ESBL-producing E. coli was 71 
reported in calves in a dairy herd in 2004 (Teale et al., 2005). A longitudinal study of one 72 
commercial dairy farm found 82.8% of calves were positive for ESBL-producing E. coli (Watson et 73 
al., 2012). Several other studies have focused on the presence of ESBL-producing E. coli in dairy 74 
cattle in the UK (Liebana et al., 2006, Horton et al., 2011, Snow et al., 2011, Watson et al., 2012) 75 
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but according to a recent study there is a lack of information on the occurrence of ESBL-producing 76 
E. coli in the gut of British beef cattle  (Horigan et al., 2016). In 2011 to 2012, a study in Germany 77 
investigated the presence of ESBL-producing E. coli in ~ 600 samples from 30 mixed dairy and 78 
beef cattle farms, 15 beef cattle farms and 10 control farms that had not used antibiotics for at least 79 
6 months (Schmid et al., 2013). Samples from mixed dairy and beef farms were significantly more 80 
likely to be positive for ESBL-producing E. coli than samples from beef cattle farms (Schmid et al., 81 
2013). Additionally, isolates from mixed dairy and beef farms were significantly more resistant to a 82 
number of antibiotics than isolates from beef cattle farms (Schmid et al., 2013).  83 
The aim of this study therefore was to investigate the presence of ESBL-producing, AmpC-84 
producing and carbapenem resistant Enterobacteriaceae in beef cattle from farms in England, Wales 85 
and Scotland, using six different selective agars to isolate Enterobacteriaceae from faeces following 86 
non-selective enrichment. Isolates identified by MALDI ToF were further characterised by PCRs, 87 
whole genome sequencing (WGS), Minimum Inhibitory Concentrations (MICs) and Pulsed Field 88 
Gel Electrophoresis (PFGE). The secondary objective was to investigate potential risk factors 89 
associated with the presence of ESBL-producing Enterobacteriaceae with an emphasis on E. coli.  90 
 91 
Materials and methods 92 
 93 
Study population and farm selection 94 
Commercial British cattle farms were selected from those participating in an existing larger study 95 
on E. coli O157 in cattle of slaughter age as previously described (Henry et al., 2017). For the 96 
present study, 40 farms (Scotland n=20 and England & Wales n=20) were systematically selected 97 
from the source population from which samples were collected on or after 13th April 2015. When 98 
the farms to be sampled in a week was determined for the larger study, one Scottish farm and one 99 
from England & Wales were randomly selected from these. On receipt of the samples, whether 100 
those selected farms provided agreement for their samples to be used for other research purposes 101 
was checked, and if a selected farm could not be used, the next available alternative was substituted. 102 
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Sample size calculation 103 
The population of 40 farms was selected to provide a crude estimate of herds positive for ESBL-104 
producing Enterobacteriaceae, i.e. herd-level prevalence, such that a 5% prevalence would be 105 
detected with an accuracy of 6.8% , so a prevalence between 0 - 11.8% could be detected with 95% 106 
confidence. Having 20 English/Welsh and 20 Scottish farms, only allowed for the detection of large 107 
differences in prevalence (>10%) between the two sets of countries.  108 
 109 
Farm visits and data collection 110 
Each study farm was visited once between April and October 2015. From each farm, individual 111 
faecal pat samples were collected from the group of finishing cattle closest to slaughter on the day 112 
of the visit. The number of animals sampled on each farm was determined by the size of the 113 
relevant group of cattle according to a protocol designed for the larger study, which assumed that if 114 
8% of animals were positive for E. coli O157, there would be a 0.9 probability of identifying groups 115 
containing at least one E. coli O157 positive animal (Chase-Topping et al., 2007, Gunn et al., 2007, 116 
Henry et al., 2017). As ESBL prevalence in beef cattle was unknown it was assumed that it would 117 
be of a similar prevalence to E. coli O157. Information on general farm characteristics, management 118 
practice and health status was collected during an interview with the farmer using a standardised 119 
questionnaire administered by the survey staff. 120 
 121 
Testing of faecal samples 122 
Faecal samples were enriched in buffered peptone water (BPW) by adding 1 gram (± 0.1 gram) of 123 
faecal sample to 9 mls of BPW, before incubating at 37ºC ± 1ºC for 18 to 22 hours. Enriched 124 
samples (10 µl) were plated to MacConkey – “MCA” agar for non-selective isolation of E. coli, to 125 
agars selective for ESBL (CHROMagar™ ESBL – “CA-ESBL” and Oxoid Brilliance™ ESBL – 126 
“BRILL”) and AmpC phenotypes (CHROMagar™ ECC + 16 mg/L cefoxitin – “CA-AMP”), and to 127 
agars selective for carbapenem resistant organisms (chromID® carba – “CARBA” and chromID® 128 
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OXA-48 – “OXA-48”). Plates were incubated at 37ºC ± 1ºC for 18 to 22 hours, with the exception 129 
of the MCA agar which was incubated at 44ºC ± 1ºC for 18 to 22 hours.  130 
All isolates of interest (one E. coli and/or Enterobacteriaceae type colony per sample per agar type) 131 
on agars were purified by streaking a single colony to a second plate of the original isolation media, 132 
prior to further tests.  133 
 134 
Identification of isolates 135 
Purified isolates were identified by MALDI ToF mass spectrometry (Autoflex II, Bruker Daltonics 136 
Ltd, UK) using the manufacturer’s Biotyper database identification software, as previously 137 
described (Mellmann et al., 2008, Randall et al., 2015).  138 
 139 
Testing for blaCTX-M, blaOXA, blaSHV and blaTEM genes by PCR 140 
Isolates that grew on the two ESBL selective agars (CA-ESBL and BRILL) were tested for the 141 
presence of ESBLs genes blaCTX-M, blaOXA, blaSHV and blaTEM using a multiplex PCR as previously 142 
described (Fang et al., 2008). Farms that were positive for blaCTX-M isolates by PCR were 143 
categorised as “CTX-M positive farms.” 144 
 145 
Minimum inhibitory concentrations (MICs) 146 
MICs were performed against a selected sub set of E. coli (n=152) from the different agars. The 147 
subset of E. coli isolates was selected to include isolates with an AmpC phenotype (n=13, from CA-148 
AMP) or ESBL phenotype from ESBL selective agars (n=21), as well as isolates from non-selective 149 
agar (MCA) from different farms (n=118). The E. coli isolates from non-selective agar were 150 
selected to provide information on antibiotic resistance in background E. coli from the different 151 
farms. 152 
MICs were performed using an agar dilution method based on that of the British Society for 153 
Antimicrobial Chemotherapy – BSAC (Andrews, 2001, BSAC, 2015). MICs were determined for 154 
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apramycin; amoxicillin : clavulanate (fixed concentration of 2 mg/L clavulanate); azithromycin; 155 
cefotaxime; ceftazidime; ciprofloxacin; colistin; neomycin; sulphamethoxazole : trimethoprim (19 : 156 
1) and tetracycline. MIC range, MIC50 and MIC90 values were calculated for each antibiotic for 157 
subsets of E. coli from different media. 158 
 159 
Pulsed-field gel electrophoresis (PFGE) 160 
Selected isolates (n=152, same isolates as selected for MICs) were analysed by pulsed field gel 161 
electrophoresis (PFGE) after genomic DNA digestion by Xba1, according to methods described 162 
previously (Ribot et al., 2006, Horton et al., 2016). Different strains were defined by using a cut-off 163 
of 80% similarity as per published guidance (Tenover et al., 1995, Ribot et al., 2006).  164 
 165 
Whole genome sequencing (WGS) 166 
DNA for WGS was prepared as previously described (Anjum et al., 2016). A total of 100 isolates of 167 
interest (Table 1) were selected for WGS based on criteria such as ESBL or AmpC phenotypes on 168 
agars, presence of blaCTX-M genes by PCR, farm, or based on MIC or PFGE results.  169 
DNA was sequenced using Illumina MiSeq and the resulting sequences were checked for quality 170 
and AMR genes as previously described (Anjum et al., 2016). The WGS “FASTQ” files before and 171 
after (for comparison) assembling using “SPAdes” (Bankevich et al., 2012) were analysed in batch 172 
analysis mode using DTU pipelines “MLST” (Larsen et al., 2012), “SerotypeFinder” (Joensen et al., 173 
2015) and “SpeciesFinder” (Larsen et al., 2014). Plasmids’ contigs were analysed using the 174 
assembled genomes as described previously (Duggett et al., 2017).  175 
AMR genes for six E. coli isolates (all ST3476) that originated from the same farm and exhibited 176 
identical AMR genotypes were fully or partially attributed to a single contig with an IncI1 rep gene 177 
using “ABRICATE” (Anonymous, 2018). For one of the isolates, “UNICYCLER” produced a 178 
circular contig of ~107 kb (p185-IncI1), and this was used as the reference (Wick et al., 2017) for a 179 
plasmid comparison across strains using “BRIG”  (Alikhan et al., 2011). 180 
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 181 
Statistical analysis – epidemiology 182 
There were five outcome measures for the statistical analyses. These were the number of samples 183 
positive for: CTX-M ESBL–producing E. coli (CTX– M E. coli), as determined by PCR; CTX-M 184 
ESBL–producing non-E. coli (CTX–M non-E. coli), as determined by PCR; CTX-M ESBL–185 
producing Enterobacteriaceae (CTX–M Enterobacteriaceae), as determined by PCR; AmpC 186 
phenotype E. coli (AmpC E. coli) on CA-AMP selective agar, and finally, carbapenem resistant E. 187 
coli on OXA-48 and CARBA selective agars. CTX–M Enterobacteriaceae were classed as those 188 
samples that were positive by PCR for blaCTX– M. 189 
Crude prevalence and 95% confidence interval of each of the outcomes was estimated at herd and 190 
individual sample (animal) level. A herd was considered positive for each outcome if at least one 191 
sample tested positive in a given test.  192 
Descriptive statistics on general farm characteristics and management practices were generated. 193 
Continuous variables, if appropriate, were categorised based on their distribution. Binary and 194 
categorical variables with few observations (less than 5%) recorded were excluded from analyses 195 
due to a low variance or re-categorised to increase the number of observations, if appropriate. 196 
Univariable and multivariable mixed effect logistic regression models were used to identify 197 
potential risk factors at sample level for the following two outcomes considered of most 198 
importance: CTX-M E. coli and AmpC E. coli. Farm ID was added as a random effect to account 199 
for the non-independence of samples from the same farm. Only variables significant at P<0.25 in 200 
the univariable analysis were considered for multicollinearity checks using the Fisher-exact test 201 
(due to structure of the data). Two variables were considered to be collinear if a P<0.01 was 202 
obtained and the variable with the stronger association with the outcome or better biological 203 
plausibility was kept for further analysis. Multivariable mixed effect logistic regression models 204 
were constructed using a forwards stepwise process starting with exposure variables with the 205 
strongest association (based on the results from univariable analysis) with the outcome. Each time 206 
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an exposure variable was added, a change in the estimates of odds ratio was visually examined and 207 
a likelihood ratio (LR) test was done to assess whether the variable should remain in the model. The 208 
statistical significance level, α, was set at a value of 0.05. Production type (beef specialist, suckler 209 
beef, dairy with beef cattle and “other” – combination of beef specialist and suckler beef) was 210 
considered to be a priori confounder (Schmid et al., 2013) and was therefore forced into the 211 
multivariable models. All statistical analysis were carried out in Stata 14 .1 (StataCorp, Texas, 212 
USA). 213 
 214 
Results 215 
 216 
Farm characteristics 217 
The median number of cattle on the 40 study farms was 73 (min=2, max=550), with a higher 218 
number of cattle on Scottish farms than on English and Welsh farms (Table 2). The most common 219 
production type amongst the study farms was suckler beef (22 farms). Two of the study farms were 220 
certified as organic production systems. The majority of the farms (28 farms) were open herds that 221 
had purchased cattle within the last 12 months, 16 farms in Scotland and 12 farms in 222 
England/Wales. The group of cattle sampled were housed at the time of sampling, as opposed to 223 
kept outdoor (grazing), on twenty-one farms (12 Scottish and nine English/Welsh). More 224 
information on farm characteristics and management practices is summarised in Supporting 225 
Information Table S1. 226 
 227 
Herd- and sample- apparent prevalence of ESBL bacteria 228 
In total, 776 faecal samples were collected from the 40 farms, ranging between 1 and 60 (mean 229 
19.4) samples per farm (Table 2). On two farms, less than five samples were collected.  230 
A total of 1,117 isolates from these samples were identified by MALDI ToF (Table 1), including 231 
425 isolates from the two ESBL agars (BRILL and CA-ESBL), 518 isolates from the CA-AMP 232 
agar, 161 isolates from the two agars to select carbapenem resistant bacteria (CARBA and OXA-233 
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48) and 13 isolates from MCA agar (most isolates from MCA were identified as presumptive E. coli 234 
only based on being lactose fermenters). Isolates from the agars that screened for carbapenem 235 
resistance were identified as Aeromonas (n=24 samples positive), Ochrobactrum (n=17 samples 236 
positive) and Pseudomonas (n=207 samples positive) species, and carbapenem resistant E. coli were 237 
not isolated.  238 
A total of 110 isolates from ESBL selective agars were tested for the presence of ESBLs genes 239 
blaCTX-M, blaOXA, blaSHV and blaTEM. All of these isolates were identified by MALDI-ToF as 240 
Citrobacter species (n=20), Escherichia coli (n=54), Morganella morganii (n=25), Proteus species 241 
(n=9) and Serraria fonticola (n=2). None of these isolates were positive for blaOXA or blaSHV genes. 242 
The blaCTX-M was detected in all Escherichia coli and Serraria fonticola isolates tested, and in 18 of 243 
the Citrobacter species isolate tested, but not in the other bacterial species tested. The blaTEM was 244 
detected in 5 CTX-M positive E. coli only. 245 
Ten (25%) farms were positive for CTX-M Enterobacteriaceae (Citrobacter, Escherichia or 246 
Serratia), nine (22.5%) farms were positive for CTX-M E. coli by PCR (all of which were also 247 
positive for CTX-M Enterobacteriaceae), with similar herd prevalence in both study regions (Table 248 
3). Three (7.5%) farms tested positive for CTX-M non-E. coli (Citrobacter or Serratia, Table 1) by 249 
PCR, all of which were Scottish farms. Two of the CTX-M non-E. coli positive farms were also 250 
positive for E. coli carrying CTX-M genes. In total 15 (37.5%) farms were positive for AmpC 251 
phenotype E. coli, with a slightly higher proportion of positive farms found in Scotland compared to 252 
England and Wales (Table 3). The difference was not statistically significant (P = 0.327).  253 
Crude estimates (not adjusted for the study design) of sample level prevalence are summarised in 254 
Table 3. In total, 52 (6.7%) samples originating from ten farms were positive by PCR for CTX-M 255 
Enterobacteriaceae, with slightly higher proportion of samples positive from England and Wales 256 
compared to Scotland (Table 3), but the difference was not statistically significant (P = 0.389). 257 
CTX-M E. coli (by PCR) were detected in 33 (4.2%) samples (from nine farms) and a significantly 258 
higher number of samples tested positive in England and Wales, compared to Scotland (P < 0.001). 259 
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CTX-M positive non-E. coli (by PCR) were isolated from 20 (2.6%) samples originated from the 260 
three positive Scottish herds. A total of 81 (10.4%) samples were positive for AmpC phenotype E. 261 
coli with significantly higher proportion of AmpC E. coli positive samples amongst Scottish herds 262 
(P<0.001). 263 
 264 
PFGE  265 
PFGE showed that the E. coli isolates from the different farms were diverse based on differences in 266 
PFGE banding patterns (Figure 1). However, where isolates were tested from different samples 267 
from the same farm, there were some examples of the same PFGE pattern from different samples 268 
suggesting distribution of the same clone within the farm.  269 
 270 
MICs 271 
A summary of MIC results for the 10 antibiotics performed against E. coli isolates can be seen in 272 
Table 4, with MIC50 and MIC90 values. For apramycin, azithromycin, colistin and neomycin, the 273 
isolates showed similar MIC50 and MIC90 values regardless of the agar of origin. As would be 274 
expected, isolates from ESBL agars (CA-ESBL or BRILL) or CA-AMP agar tended to show 275 
reduced susceptibility to the β-lactam antibiotics cefotaxime and ceftazidime, and to the potentiated 276 
β-lactam antibiotic amoxicillin/clavulanate, compared to isolates from MCA. Additionally, isolates 277 
from ESBL and CA-AMP agars tended to have increased MIC50 and / or MIC90 values for 278 
sulphamethoxazole/ trimethoprim (SXT) and / or tetracycline compared to isolates from MCA. 279 
Also, isolates from ESBL agars, but not from CA-AMP agar, tended to have increased MIC90 values 280 
for ciprofloxacin, compared to isolates from MCA. 281 
 282 
Risk factors at the sample level 283 
Risk factors analyses were carried out for the following two outcomes: CTX-M E. coli and AmpC 284 
E. coli. Of the sixty-four potential risk factors, 14 were excluded due to a low variance or due to 285 
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holding information collected only from a group of farms (i.e. additional information on housing 286 
collected from farms where cattle were housed as opposed to being kept outdoor – grazing) 287 
(Supporting Information Table S1). Based on the results of the univariable analysis (P≤0.25), 288 
variables considered for the multivariable analyses are summarised in Table 5. In the multivariable 289 
analysis, accounting for the effect of production type, buying breeding bulls and changes in feeding 290 
in the last two weeks before the sample collection, significantly increased odds of a sample being 291 
positive for CTX-M E. coli (Table 6). Presence of cats significantly decreased odds of a sample 292 
being positive for CTX-M E. coli (OR=0.03, 95% CI: 0.0-0.3) when added to the model, however it 293 
was excluded due to collinearity with the production type. 294 
Bringing in cattle for fattening from other farms and the spreading of a farm’s own manure were 295 
significantly associated with an animal being positive in the univariable analysis for AmpC E. coli 296 
(Table 5). In the multivariable analysis, bringing in cattle for fattening from other farms, animals on 297 
farms located in Scotland and being a dairy farm with beef cattle present, had significantly 298 
increased odds of being positive for AmpC E. coli (Table 6). There was no collinearity (P <0.01) 299 
detected between the three exposure variables included in the model, although a significant 300 
association was detected between production type and bringing in cattle for fattening from other 301 
farms (P = 0.016). 302 
 303 
Whole genome sequencing (WGS), multidrug resistance and plasmid analysis 304 
WGS was performed on selected isolates (n=100), of which 96 isolates gave results suitable for 305 
analysis using DTU pipelines as summarised in Table 1. There was a reasonable correlation 306 
between the AMR genotype and MIC resistance phenotype for isolates tested (Table 4), bearing in 307 
mind that not all isolates that were MIC tested were also sequenced.  308 
The presence of antibiotic resistance genes detected by WGS in Citrobacter, E. coli and Serratia 309 
(only Citrobacter, E. coli and Serratia were found to be positive for blaCTX-M genes) from the 310 
different agars is shown in Table 7.  311 
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As would be expected, the 30 isolates from MCA were positive for the least number of resistance 312 
genes, with only 5 resistance genes encoding resistance to a total of three different classes of 313 
antibiotic (Table 7). Resistance genes in these isolates were also found to older antibiotics, with no 314 
ESBL or quinolone resistance genes detected. From the 16 isolates from CA-AMP there were a 315 
total of 16 different resistance genes detected, representing resistance to 8 different classes of 316 
antibiotic (Table 7). Isolates from CA-AMP, as would be expected, included three different AmpC 317 
genes, but also genes encoding resistance to phenicols, quinolones and other classes of antibiotics, 318 
but not ESBL genes (Table 7). The 24 isolates from ESBL agars had the most resistance genes 319 
(n=30), encoding resistance to 8 classes of antibiotics, including five different blaCTX-M genes 320 
detected (Table 7).  321 
There were six E. coli isolates (all ST3476) that originated from the same farm and exhibited 322 
identical AMR genotypes (blaCTX-M-1, sul2, tetA). A plasmid comparison across strains was 323 
performed using BRIG (Figure 2). The BRIG image indicated that there was high similarity 324 
amongst the isolates, and that the blaCTX-M-1, sul2 and tetA were co-located on the plasmid. 325 
However, whilst the IncI1 blaCTX-M-1 plasmid present in these isolates essentially had the same 326 
backbone, it harboured some differences in its gene content. When compared to plasmids on NCBI, 327 
p185-IncI1 showed 99% identity to an isolate (GenBank Accession: KT779550.1) from a one-day-328 
old chick treated in an experimental study with a 3rd generation cephalosporin in France in 2016 329 
(Baron et al., 2016). Interestingly, a seventh E. coli from the same farm, also ST3476, contained no 330 
AMR genes or IncI1 suggesting that the plasmid was either lost or had not transferred to this host. 331 
 332 
Discussion 333 
 334 
This is the first study aiming to investigate the occurrence of ESBL-producing Enterobacteriaceae 335 
(mainly E. coli) in the gut of beef cattle in the UK, and to perform characterisation of isolates. 336 
The source population for this survey was the 270 farms that participated in a larger study on E. coli 337 
O157 in cattle in Great Britain (Henry et al., 2017). The 40 herds included in this current study were 338 
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not selected at random, participation in additional research was voluntary and the subset selected 339 
was seasonal compared to the original study (April - October 2015 compared with September 2014 340 
- November 2015). Therefore, there is potential for bias in the estimates of occurrence, if these 341 
factors are systematically associated with any of the outcomes of interest. No formal validation of 342 
these data was carried out. The estimated average herd size (based on number of cows) of the study 343 
farms was smaller than that reported for dairy and beef herds in 2014 (AHDB, 2016), which was 344 
based on animals of two years of age or over with offspring, except for Wales, where all animals 345 
over two years of age were included. This may indicate that a number of the farms were not 346 
representative of the British cattle population. It is however unknown whether herd size would have 347 
influenced the status of the farms, and whether this bias would have been important to our study’s 348 
ability to be representative of the cattle population. In our study, herd size was not significantly 349 
associated with the presence of E.coli CTX-M and AmpC phenotype E. coli positive samples.   350 
The results showed no sample/herd being positive for carbapenemase-producing E coli. Isolates 351 
from the carbapenem agars were identified mainly as Aeromonas, Ochrobactrum and Pseudomonas 352 
species. These bacteria occur in habitats such as soil, sewage and the guts of mammals, are 353 
generally considered as opportunist pathogens, and may be intrinsically resistant to carbapenem 354 
antibiotics, although this was not investigated.  355 
CTX-M Enterobacteriaceae and CTX-M E. coli positive herds were found in both study regions, but 356 
no significant differences in herd-level prevalence were observed. However, the results at regional 357 
level should be interpreted with caution as the sample size was not sufficient to estimate the herd 358 
prevalence at this level with a high degree of accuracy, and only large differences (>10%) would be 359 
detected with confidence.  360 
At sample level, significantly higher proportion of samples positive for CTX-M E. coli were 361 
detected in herds from England and Wales compared to the herds in Scotland (P < 0.001). On 362 
average the same number of samples was collected from the majority of study farms in both regions 363 
which made comparison good. However, on one farm, only one sample was collected, which was 364 
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less than expected, resulting in potential misclassification of the herd status with respect to the study 365 
outcomes. Furthermore, the presented estimates of positive samples are crude estimates, as they 366 
don’t account for the complex study design (i.e. non-random selection of farms from the 367 
subpopulation of farms participating in the existing larger study), so should be considered as an 368 
indication of the level of occurrence of ESBL producing Enterobacteriaceae in beef cattle prior to 369 
slaughter. The estimated prevalence for the three ESBL outcomes were below the 8% expected 370 
prevalence used for the sample size calculation which will have decreased the confidence around 371 
these estimates.  372 
Compared to two similar studies carried out in dairy and beef cattle in Germany (Schmid et al., 373 
2013, Hille et al., 2017), the study results suggest that herd- and sample-level estimates of CTX-M 374 
E. coli in beef cattle in GB were much lower. Whilst the methodology of isolation of ESBL-375 
producing and AmpC phenotype E. coli in these two studies were not identical to those used in this 376 
study, they were similar in that they did involve a pre-enrichment stage and then plating onto 377 
selective agar (MacConkey agar plates containing 1 mg/l cefotaxime). 378 
Other European studies, although not directly comparable, estimated cattle prevalence (at the 379 
animal level) of ESBL producing Enterobacteriaceae as 8.4% in Switzerland (Reist et al., 2013), 380 
and of CTX-M E. coli as 4.8% in France (Hartmann et al., 2012).  381 
Knowledge of the risk factors is important to inform identification of suitable control measures and 382 
surveillance programmes. No associations were detected between the cattle treatment in the last 383 
three months before sampling or health problems in the last two weeks before sampling. This 384 
suggests that there were also other factors that may have played an important role in introduction 385 
and/or transmission of resistant organisms, and/or lack of power to detect a difference given the 386 
small sample size. The identified risk factors related mainly to herd management and are in 387 
agreement with previous studies. Bringing new animals in significantly increased the risk of the 388 
sample being positive for CTX-M E. coli and for AmpC phenotype E. coli as observed by  Reist et 389 
al. (2013) and Snow et al. (2012). 390 
16 
 
Changes in feeding two weeks before sampling significantly increased the risk of the sample testing 391 
positive for CTX-M E. coli (Table 5). This could be indicative of an increased stress as a result of 392 
the change and increased disease susceptibility of the animals as also reported by Hille et al. (2017). 393 
Dairy herds with beef cattle had significantly increased odds of the sample being positive for AmpC 394 
phenotype E. coli as previously reported (Reist et al., 2013, Schmid et al., 2013, Hille et al., 2017). 395 
In dairy herds, cows are often treated with antibiotics at time points throughout their life, whereas 396 
cattle in beef herds are more likely to be treated during the earlier stages of their life rather than 397 
close to slaughter (Hille et al., 2017). Further explanations can be related to certain management 398 
practices on dairy farms, such as feeding waste milk to calves. A survey showed 90% of UK farms 399 
fed waste milk to calves (Brunton et al., 2012), whilst another study showed that 21.4% of waste 400 
milk samples contained residues of the cephalosporin cefquinome, which was significantly 401 
associated with CTX-M bacteria in the waste milk (Randall et al., 2014b). 402 
Whole genome sequencing provided an insight into the resistance genes detected in E. coli isolated 403 
from the different agars (e.g. isolates from MCA, CA-AMP and ESBL agars) which correlated with 404 
the major phenotypes present. Although isolates from ESBL and CA-AMP agar both had resistance 405 
genes to 8 different classes of antimicrobials, the isolates from ESBL agar has almost twice the 406 
number of resistance genes compared to isolates from CA-AMP with many isolates from the former 407 
harbouring multiple allelic variants of genes encoding resistance to the same antimicrobial. Plasmid 408 
analysis of six E. coli isolates that originated from the same farm and exhibited identical AMR 409 
genotypes (blaCTX-M-1, sul2, tetA) showed that the blaCTX-M-1, sul2 and tetA genes were co-410 
located on the same plasmid. Therefore, the use of cephalosporin, sulphonamide and tetracycline 411 
antibiotics could all co-select for this plasmid; a similar observation has also been made by others 412 
for MDR isolates (Canton and Ruiz-Garbajosa, 2011). Presence of multiple isolates of the same ST 413 
harbouring a similar CTX-M-1 IncI1 plasmid isolated from different samples provided evidence 414 
that this E. coli clone can easily disseminate between animals on the same farm. Some differences 415 
in the IncI1 plasmid gene content confirmed the elasticity of plasmid genomes as we have shown 416 
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previously with mcr-1 harbouring plasmids which have been detected in the UK and worldwide 417 
(Duggett et al, 2017). 418 
In conclusion, this study provided new evidence of the level of occurrence of ESBL-producing 419 
Enterobacteriaceae in GB beef cattle and the presence of antibiotic resistance genes in such isolates. 420 
None of the farms were positive for carbapenem resistant E. coli.  There were no regional 421 
differences between farms in England, Wales and Scotland, thus a proportion of beef cattle in GB 422 
can be considered to harbour ESBL producing Enterobacteriaceae. Analysis of risk factors was 423 
limited by the scale of this study, but a number of significant factors were identified at animal level. 424 
These related mainly to farm management that indicate potential routes for introduction and 425 
transmission of resistant organisms / genes, with the possible addition of stress as a result of 426 
changes in feeding.  427 
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Table 1. Background details of isolates that were whole genome sequenced (n=96) 652 
 653 
Isolation agar(s) No. of 
isolates 
identified by 
MALDI ToF 
No. of isolates 
selected for WGS 
No. of farms with 
isolates on which 
WGS was 
performed 
No. of  isolates 
identified as 
Citrobacter, E. 
coli or Serratia* 
from WGS 
No. of WGS 
isolates that tested 
positive for 
blaCTX-M by PCR 
No. of farms with 
WGS isolates 
positive by PCR 
for blaCTX-M 
MCA 13 (834†) 34 27 30 0 0 
ESBL agars 425 37 16 24 23 10 
CA-AMP 518 24 18 16 0 0 
CARBA and OXA-48 161 1 1 0 0 0 
 654 
* - Citrobacter, E. coli and Serratia were the only three bacterial species that were positive by PCR for blaCTX-M . In absence of MALDI ToF 655 
results for most isolates from MCA, bacterial identity was taken from WGS results.  656 
 657 
† – Most (834) isolates from MCA were identified as presumptive E. coli (lactose fermenters), and were not identified by MALDI ToF 658 
 659 
 660 
 661 
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Table 2. Summary of frequency distributions of continuous variables describing the number 662 
of cattle (by different age groups) and number of samples collected for all farms (n=40). 663 
 664 
Variable  Mean 
(SD*) 
Percentiles 
10th 25th 50th 75th 90th 
Number of samples 
collected 
England & Wales 19.4 (11.2) 9 12 19 23 24 
 Scotland    19.4 (9.8) 10 12 19 23 31 
 Combined 19.4 (10.4) 10 12 19 23 29 
Number of cattle in the 
sample group 
England & Wales 16.6 (17.3) 6 8 14 19 22 
 Scotland 16.1 (10.8) 7 9 15 19 29 
 Combined 16.3 (14.2) 6.5 9 14 19 26 
Youngest animal 
sampled in the group 
(months) 
England & Wales    13.7 (4.9) 8 11 12 16 21 
 Scotland 15.8 (4.9) 10 11 17 22 24 
 Combined 14.8 (5.3) 10 11 13 18 24 
Oldest animal sampled 
in the group 
(months) 
England & Wales  21.6 (13.7) 12 14 17 26 33 
 Scotland  21.3 (10.5) 12 15 21 25 26 
 Combined  21.4 (12.1) 12 14 19 25 29 
Number of heifers per 
farm 
England & Wales 9.8 (15.2) 0 0 3 8 36 
 Scotland 12.2 (21.2) 0 0 4.5 12.5 41 
 Combined 11.0 (18.2) 0 0 3 11 36 
Number of cows per 
farm 
England & Wales 51.4 (75.9) 0.5 14 26 49 160 
 Scotland 39.8 (41.5) 0 0 35 59 110 
 Combined 45.6 (60.7) 0 6 29 50 125 
Number of calves (≤1 
year old) 
England & Wales 28.0 (35.3) 0 10 20 29 88 
 Scotland 51.0 (79.4) 0 3 29 62 113 
 Combined 39.3 (61.7) 0 7 21 41 108 
Cattle 12-30 months England & Wales 25.9 (30.8) 0 6.5 14 37 73 
 Scotland 50.4 (70.4) 1 8 26 60 122 
 Combined 38.1 (57.3) 0 8 18 53 86 
Number of bulls over 1 
year of age 
England & Wales 2.2 (4.4) 0 0 1 2 5 
 Scotland 1.1 (1.2) 0 0 1 2 3 
 Combined 1.6 (3.2) 0 0 1 2 4 
Total number of cattle 
per farm 
England & Wales 117.0 (129.6) 23 42 64 137 351 
 Scotland 153.9 (145.9) 29 40 99 222 370 
 Combined 135.5 (137.5) 28 41 73 177 367 
* SD = standard deviation 665 
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Table 3. Herd- and sample- level crude prevalence (and 95% confidence intervals). Data collected as part of the study of 40 farms conducted 666 
between April and October 2015. 667 
 % positive (95% Confidence interval) 
Herd-level England & Wales (N=20) Scotland (N=20) Combined (N=40) 
E. coli CTX-M (PCR) 25 (8.6-49.1) 20 (5.7-43.7) 22.5 (10.8-38.4) 
Non- E. coli CTX-M (PCR) 0 15 (3.2-37.9) 7.5 (1.6-20.4) 
Enterobacteriaceae CTX-M (PCR) 25 (8.6-49.1) 25 (8.6-49.1) 25 (12.7-41.2) 
E. coli AmpC phenotype 30 (11.9-54.3) 45 (23.1-68.5) 37.5 (22.7-54.2) 
Sample-level England & Wales (N=388) Scotland (N=388) Combined (N=776) 
E. coli CTX-M (PCR) 7.5 (5.1-10.6) 1.0 (0.0-2.6) 4.2 (2.9-5.9) 
Non- E. coli CTX-M (PCR) 0 5.1 (3.1-7.8) 2.6 (1.5-3.9) 
Enterobacteriaceae CTX-M (PCR) 7.5 (5.1-10.6) 5.9 (3.8-8.8) 6.7 (5.0-8.7) 
E. coli AmpC phenotype 3.8 (2.1-6.3) 17.0 (13.4-21.1) 10.4 (8.3-12.8) 
 668 
669 
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 670 
Table 4. Minimum inhibitory concentration (MIC) (mg/L) parameters of 10 antibiotics against selected E. coli 671 
 672 
Species Agar 
No. 
tested 
MIC range (mg/L) and (MIC50 / MIC90) 
   AMC APR AZM CAZ CTX CIP CST NEO SXT TET 
E. coli* MCA 119 
0.25- 128 
(2 / 4) 
1-64 
(4 / 4) 
0.5-8 
(4 / 4) 
0.06->128 
(0.25 / 1) 
0.015-8 
(0.06 / 0.13) 
0.008-2 
(0.015 / 0.03) 
0.13->128 
(0.5 / 1) 
1-64 
(1 / 2) 
0.25->128 
(1 / 2) 
0.13->128 
(1 / 2) 
E. coli 
ESBL 
agars† 
22 
2->128 
(16 / >128) 
2-4 
(4 / 4) 
2-4 
(4 / 4) 
0.25-64 
(2 / 16) 
4-128 
(32 / 64) 
0.008-8 
(0.015 / 0.5) 
0.25->128 
(0.25 / 0.5) 
1-4 
(1 / 2) 
0.5->128 
(2 / >128) 
1->128 
(64 / 64) 
E. coli FOX 11 
2->128 
(128 / >128) 
1-8 
(4 / 4) 
2-8 
(4 / 8) 
2-32 
(8 / 32) 
1-8 
(2 /8 ) 
0.008-0.25 
(0.015 / 0.03) 
0.25-64 
(0.5 / 0.5) 
1-64 
(2 / 4) 
0.25->128 
(2 / >128) 
1->128 
(1 / >128) 
All E. coli All above 152 
0.25->128 
(4 / 16) 
1-64 
(4 / 4) 
0.5-8 
(4 / 4) 
0.06->128 
(0.5 / 8) 
0.015-128 
(0.06 / 32) 
0.008-8 
(0.015 / 0.06) 
0.13->128 
(0.5 / 1) 
1-64 
(1 / 2) 
0.25->128 
(1 / 4) 
0.13->128 
(1 / 64) 
All CTX + 
ESBL 
agars† 
22 
2->128 
(16 / >128) 
2-4 
(4 / 4) 
2-4 
(4 / 4) 
0.25-64 
(2 / 16) 
4-128 
(32 / 64) 
0.008-8 
(0.015 / 0.5) 
0.25->128 
(0.25 / 0.5) 
1-4 
(1 / 2) 
0.5->128 
(2 / >128) 
1->128 
(64 / 64) 
AMR genes detected by WGS in isolates 
that can confer resistance to associated 
antibiotic. Not all of the above isolates 
were whole genome sequenced. 
blaACT 
blaCMY-2 
blaCMY-77 
blaDHA-1 
blaDHA-2 
 mphA 
blaCTX-M-1 
blaCTX-M-8 
blaCTX-M-15 
blaCTX-M-24 
blaCTX-M-32 
blaCTX-M-1 
blaCTX-M-8 
blaCTX-M-15 
blaCTX-M-24 
blaCTX-M-32 
qnrB5 
qnrB19 
qnrS1 
gyrA
‡
 
 parC
‡
 
pmrA
‡
 
pmrB
‡
 
phoP
‡
 
phoQ
‡
 
aph(3')-Ic 
dfr+ 
sul2, 3 
tet(A) 
tet(B) 
tet(D) 
tet(41) 
   673 
AMC - amoxicillin : clavulanate (fixed concentration of 2 mg/L clavulanate), APR – apramycin, AZM – azithromycin, CAZ – ceftazidime, CTX 674 
– cefotaxime, CIP – ciprofloxacin, CST – colistin, NEO – neomycin, SXT - sulphamethoxazole : trimethoprim (19 : 1), TET – tetracycline.  675 
ND – MIC50 values were not determined for less than 10 isolates. 676 
 677 
* – Isolates from McC agar were presumptive E. coli on the basis of growing as lactose fermenters at 44ºC. Other E. coli were confirmed as such 678 
by MALDI-ToF.  679 
† – ESBL agars - CA-ESBL or BRILL.  680 
‡ - Genes with non-synonymous SNPs. 681 
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Table 5. Results of exposure variables associated with the presence of CTX-M E.coli and 682 
AmpC phenotype E. coli positive samples in the univariable mixed effect logistic regression 683 
models (P ≤ 0.25) and the production type as a priori variable. 684 
Variable Level OR 95% CI P-value 
CTX-M E. coli 
Production type Suckler beef 1  0.824 
 Specialist finisher 0.32 0.00-15.93  
 Dairy with beef 0.13 0.00-13.68  
 Other* 0.00 -  
Region England & Wales 1  0.233 
 Scotland 0.17 0.00-3.11  
Cats No 1  0.023 
 Yes 0.02 0.00-0.59  
Breeding bulls other 
farms/buying bulls 
No 1  0.004 
 Yes 57.78 3.53-944.92  
Isolation of other farm 
animals 
No 1  0.077 
 Yes 14.29 0.74-274.05  
Changed feeding last 2 weeks No 1  0.033 
 Yes 22.06 1.27-383.04  
Changed location last 2 
weeks 
No 1  0.064 
 Yes 14.06 0.85-231.28  
 Level OR 95% CI P-value 
AmpC E. coli     
Production type Suckler beef 1  0.293 
 Specialist finisher 6.76 0.42-109.81  
 Dairy with beef 12.46 0.73-213.16  
 Other1 2.70 0.14-51.87  
Region England & Wales 1  0.059 
 Scotland 6.85 0.92-50.79  
Ducks on farm No 1  0.172 
 Yes 10.22 0.36-288.45  
Geese on farm No 1  0.150 
 Yes 19.44 0.33-
1114.07 
 
Horses No 1  0.168 
 Yes 0.15 0.01-2.22  
Fattening other farm No 1  0.013 
 Yes 27.93 1.98-393.28  
Bulls sharing No 1  0.213 
 Yes 7.43 0.31-175.78  
Cattle to show events No 1  0.242 
 Yes 11.27 0.19-654.80  
Cattle housing Grazing (outdoor) 1  0.138 
27 
 
 Housed 4.43 0.62-31.77  
Isolation of other farm 
animals 
No 1  0.101 
 Yes 5.46 0.71-41.81  
Spread manure own No 1  0.040 
 Yes 0.12 0.01-0.90  
 685 
OR = crude (unadjusted odds ratio), CI = confidence interval, P-value (Wald chi-squared). 686 
 687 
* Other = combination of beef specialist and suckler beef 688 
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Table 6. Risk factors associated with the presence of CTX-M E.coli and AmpC phenotype E. coli positive samples in the final multivariable 689 
mixed effect logistic regression model in beef cattle in Great Britain.  690 
E. coli type Management practice Level OR 95% CI P-value 
* CTX-M by PCR Buying bulls No 1   
 Yes 57.7 2.4-1379.2 0.012 
 Changes in feeding last 2 weeks No 1   
 Yes 14.3 1.4-147.6 0.026 
† AmpC phenotype Bringing in fattening cattle from other farm No 1   
 Yes 34.3 1.8-660.2 0.019 
 Region England & Wales 1   
  Scotland 6.3 1.0-38.4 0.047 
 Management type Suckler beef 1   
 Beef specialist 0.58 0.0-9.3 0.701 
 Dairy with beef 13.4 1.3-134.6 0.027 
 Other ‡ 0.46 0.0-7.1 0.580 
 691 
OR = odds ratio, CI = confidence interval 692 
 693 
* Wald chi-squared = 12.63, P=0.027 694 
† Wald chi-squared = 13.25, P=0.021 695 
‡ Other = combination of beef specialist and suckler beef 696 
697 
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Table 7. Resistance genes detected by WGS in Citrobacter, E. coli and Serratia*  isolates from different agars.   698 
 699 
Resistance to 
antibiotic class 
Agar origin for isolation (number of isolates) 
MCA (n=30) CA-AMP (n=16) ESBL - BRILL & CA-ESBL (n=24) 
Aminoglycosides strA, B 
 
aac(6')-Ic; aph(3')-Ic; strA, B aac(3)-Iid, aadA1, A2; strA, B 
Beta-lactams blaTEM-1C blaACT-7; blaCMY-70; blaCMY-77; 
blaTEM-1B. 
blaCTX-M-1, 8, 15, 24, 32; blaDHA-2; 
blaFONA-2, 3, 5; blaTEM-1B 
Fosfomycin - 
 
fosA - 
Macrolides - 
 
- 
 
 mph(A) 
Phenicols 
(e.g. chloramphenicol) 
- 
 
catA1; floR 
catA2; cmlA1; floR 
Quinolones - 
 
qnrB6 qnrB19; qnrS1 
Sulphonomides 
 
sul2 sul2 sul 2, 3  
Tetracyclines tetA 
 
tet(41, B) tet(A, B, D) 
Trimethoprim 
 
- 
 
dfrA5 dfrA1, 5, 12, 17  
Total number of 
resistance gene 
5 16 30 
 700 
*  – The presence of antibiotic resistance genes were compared in this table for Citrobacter, E. coli and Serratia isolates only, so that the same 701 
bacterial species were compared across different agars.  702 
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Figure 1. PFGE profiles of E. coli (n=152) isolates from cattle after Xba1 digestion.   703 
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Figure 2. Common circulating plasmid from different samples from the same farm.  705 
 706 
 707 
 708 
 709 
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 710 
 711 
 712 
Legend for figure 2. 713 
